TG

Thomas Goebel

Principal at NeoMed

Geneva, Geneva

Overview 

Thomas Goebel is currently a Principal at NeoMed, with a background in investment and management roles in various healthcare and biotech companies. With a Ph.D. from the University of Geneva, he has successfully led investments in companies such as Diagnoplex and has held director positions at Kuros Biosurgery AG and NovaShunt AG.

Work Experience 

NeoMed Management

  • Principal

    2005 - 2022

Diagnoplex SA

  • Director

    2008 - 2015

Kuros Biosurgery AG

  • Director

    2013 - 2015

NovaShunt AG

  • Director

    2007 - 2011

P&

Pictet & Cie

  • Analyst

    2000 - 2005

F

Firmenich

  • Manager Regulatory Affairs

    1988 - 2000

Firmenich is creating fragrances and flavors for the worlds most desirable brands, delighting billions of consumers every day.

firmenich.com

Education 

Investments 

Diagnoplex

Series A

Total funding: $9M

Articles About Thomas

Relevant Websites